Capricor Investors Alert: Join the Class Action Today
Recent Developments for Capricor Therapeutics Investors
The Gross Law Firm has issued an important notice for shareholders of Capricor Therapeutics, Inc. (NASDAQ: CAPR) regarding a class action lawsuit. This legal action impacts investors who acquired shares during a specified period, urging them to participate in seeking justice.
Why Should Investors Be Concerned?
Investors who purchased shares during the period from October 9, 2024, to July 10, 2025, may have incurred losses due to misleading statements and failure to disclose significant information regarding Capricor's lead therapy candidate, deramiocel. The action highlights the necessity for investors to stay informed and proactive.
Details About the Allegations
The allegations against Capricor include the transmission of inaccurate claims regarding its ability to secure a Biologics License Application from the FDA for deramiocel. Despite their optimistic outlook, the company withheld crucial safety and efficacy data from its Phase 2 HOPE-2 trial. This eventually led to a substantial stock price decline following the FDA's Complete Response Letter, which cited deficiencies in the application.
Key Dates for Participants
Investors are urged to act quickly since the deadline to register for the class action lawsuit is September 15, 2025. Delaying registration could result in a loss of the opportunity to seek compensation. This registration helps ensure that the voices of affected investors are heard.
What to Expect After Registration?
After registering, affected shareholders will have access to a portfolio monitoring tool that keeps them updated on the lawsuit's progress. The Gross Law Firm emphasizes that being a lead plaintiff is not necessary to recover damages from this case.
Why Choose The Gross Law Firm?
The Gross Law Firm is renowned for its commitment to investor rights. They focus on helping clients who have been misled by the companies in which they invest. Their dedication ensures that stakeholders are represented vigorously against unethical business practices. This mission positions them as a strong ally for investors looking to reclaim losses.
Contact Information
For more information or inquiries, investors can connect with The Gross Law Firm. The firm's office is located at:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: dg@securitiesclasslaw.com
Phone: (646) 453-8903
Frequently Asked Questions
What is the purpose of the class action lawsuit?
The class action serves to address grievances of investors misled by Capricor's false statements regarding the safety and efficacy of its drug.
Who qualifies to join the lawsuit?
Investors who purchased CAPR shares between October 9, 2024, and July 10, 2025, are eligible to register and participate in the class action.
What are the critical dates I should remember?
The registration deadline for this lawsuit is September 15, 2025, so timely action is essential.
When will I receive updates after registering?
Shareholders who register will receive ongoing updates regarding the status of the case and related developments.
What should I do if I have further questions?
For additional inquiries, contact The Gross Law Firm directly by phone or email as provided above.
About The Author
Contact Ryan Hughes privately here. Or send an email with ATTN: Ryan Hughes as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.
